For the first time in decades, the pharmaceutical industry has been directly affected by a geopolitical trade negotiation ...

US mRNA specialist Moderna has today reported financial results and provided business updates for the second quarter of 2025, ...

US President Donald Trump has sent letters to leading pharmaceutical manufacturers outlining the steps they must take to ...

CSL Behring, a part of Australia’s’ CSL Limited, today announced that the board of directors of the Italian Medicines Agency ...

Frazier Life Sciences (FLS), a US investment firm focused on innovative therapeutics, has announced the closing of its ...

US pharma major Eli Lilly has announced top-line results from SURPASS-CVOT, a first-of-its-kind head-to-head Phase III ...

The US Food and Drug Administration (FDA) is requiring safety labeling changes to all opioid pain medications to better ...

Esteve CDMO (Esteve Química) - part of privately-held Spanish drugmaker Lab Esteve - has acquired Regis Technologies, a ...

Shares of Spanish plasma-derived medicines specialist Grifols rose 9% yesterday after it announced results for the first half ...

The US Food and Drug Administration has set prescription drug user fee rates for fiscal year 2026, with increases across all ...

Bristol Myers Squibb (NYSE: BMY) has posted better-than-expected second-quarter 2025 results, driven by strong sales of its ...

Endometriosis remains a complex challenge for patients and drug developers, with GlobalData highlighting five major gaps ...